Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the…
By F. Werf, Jeroen J. Bax, A. Betriu, C. Blomström-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith A Fox, Kurt Huber, A. Kastrati and 35 more. European Heart Journal, 2008
2,255 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/86e27d42ae9eb1bc0d79e20bc99657504388f7d6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- I. Graham
- J. Halperin
- Jose Luis Zamorano
- Judith Hochman
- M. Creager
- C. Yancy
- M. Gheorghiade
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, background): “*In patients with MI, statin therapy should be considered irrespective of LDL-C levels.(13,14) Class of recommendation Level of evidence.”
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “STEMI and a large area of myocardium at risk or hemodynamic instability if PCI is unavailable.(4,48)”
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012, neutral): “6).(1,156,184) In OASIS-6, fondaparinux was superior to UFH in a subgroup of 1641 such patients and might be the preferred antithrombin for this indication.”